Leadership in endovascular bifurcation revascularization

We are a pre-commercial stage private medical technology company focused on developing and commercializing percutaneous implants for the treatment of bifurcation lesions such as Left Main disease. In the USA, a large number of patients diagnosed with this life-threatening disease are ineligible for surgery and no interventional option is approved. Poseidon is well positioned to produce the first device with a Left Main PCI FDA indication to solve this significant unmet need.